Form 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY
Rule 8.5 of the Takeover Code (the “Code”

Hypercharge Completes Acquisition of REVS Charging LLC

VANCOUVER, British Columbia, Oct. 01, 2026 (GLOBE NEWSWIRE) — Hypercharge Networks Corp. (TSXV: HC; OTC: HCNWF; FSE: PB7) (the “Company” or “Hypercharge”), a leading EV charging operator, is pleased to announce, further to its news releases dated September 11 and September 28, 2026, that it has completed its previously announced acquisition of 100% of the equity interests of REVS Charging LLC (“REVS“) (the “Transaction”) following receipt of the acceptance of the TSX Venture Exchange (the “TSXV“). In connection with the closing of the Transaction, the Company has issued REVS, 18,000,000 common shares (the “Closing Shares”), subject to a six-month voluntary lockup (the “Lockup”).

James Altucher: With One Merger and One Factory, Elon Musk Now Controls Nearly Every Layer of Artificial Intelligence

In a new presentation, top tech analyst breaks down how Musk connected the rockets, the satellites, the AI, and now the chips, and points to the one piece he says Musk still relies on an outside company to provide.

In a new presentation, top tech analyst breaks down how Musk connected the rockets, the satellites, the AI, and now the chips, and points to the one piece he says Musk still relies on an outside company to provide.

Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair

ALACHUA, Fla. and TAMPA, Fla., Oct. 01, 2026 (GLOBE NEWSWIRE) — Axogen, Inc. (“Axogen” or the “Company”) (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that it has completed its previously announced acquisition of BioCircuit Technologies, Inc. (“BioCircuit”), a privately held medical device company and developer of NerveTape™.

Univest Securities, LLC Announces Closing of $2.0 Million Registered Direct Offering for its Client Neo-Concept International Group Holdings Ltd (NASDAQ: NCI)

New York, Oct. 01, 2026 (GLOBE NEWSWIRE) — Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the “Offering”) of approximately $2.0 million for its client Neo-Concept International Group Holdings Ltd (“NCI” or the “Company”), a one-stop apparel solution services provider.

Univest Securities, LLC Announces Closing of $2.0 Million Registered Direct Offering for its Client Neo-Concept International Group Holdings Ltd (NASDAQ: NCI)

New York, Oct. 01, 2026 (GLOBE NEWSWIRE) — Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the “Offering”) of approximately $2.0 million for its client Neo-Concept International Group Holdings Ltd (“NCI” or the “Company”), a one-stop apparel solution services provider.

Vortex Energy Completes Acquisition of the Meadows Project in Saskatchewan

VANCOUVER, British Columbia, Oct. 01, 2026 (GLOBE NEWSWIRE) — Vortex Energy Corp. (CSE: VRTX) (OTC: VTECF) (FSE: AA3) (“Vortex” or the “Company“) is pleased to announce that, further to its news release dated September 17, 2026, it has completed the acquisition (the “Acquisition”) of the Purchased Assets (as defined below) comprising the Meadows Project located in west-central Saskatchewan near the Alberta border (the “Meadows Project“). 

PharmaCorp Closes Two Previously Announced Acquisitions and Provides Acquisition Pipeline Update

SASKATOON, Saskatchewan, Oct. 01, 2026 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX), a Canadian pharmacy acquisition and ownership platform, announced today that, further to its August 18, 2026, news release, it has completed the acquisition of a 100 per cent interest in a PharmaChoice Canada-bannered pharmacy located in Western Canada (the “Pharmacy Acquisition”), pursuant to the previously disclosed share purchase agreement dated August 10, 2026.

Verisk to Announce Fiscal Third-Quarter 2026 Results on November 5, 2026

JERSEY CITY, N.J., Oct. 01, 2026 (GLOBE NEWSWIRE) — Verisk (Nasdaq: VRSK), a leading strategic data analytics and technology partner to the global insurance industry, will report its financial results for the fiscal third quarter ended September 30, 2026, on Thursday, November 5, 2026, before the market open. The press release, with accompanying financial information, will be posted on the Verisk investor website at http://investor.verisk.com.

ESCO Completes Acquisition of Megger Group Limited

St. Louis, Oct. 01, 2026 (GLOBE NEWSWIRE) — ESCO Technologies Inc. (NYSE: ESE) today announced that it has completed the acquisition of the Megger Group Limited (Megger) business of TBG AG (TBG). Under the terms of the transaction, TBG has agreed to certain lock-up provisions with respect to its equity ownership in ESCO common stock and has nomination rights for one seat on ESCO’s Board of Directors.